This is further supported by the fact that subtype 3 is characterized by a high frequency of mutations with large CCF values in TP53, a major driver in all cancers but especially crucial in COAD progression where TP53 mutations are associated with drug resistance and poor prognosis [54]. Here, TP53 is linked to cancer.